Skip to content
2000
Volume 11, Issue 2
  • ISSN: 1389-2002
  • E-ISSN: 1875-5453

Abstract

Various types of nanoparticles, such as liposomes, polymeric micelles, dendrimers, superparamagnetic iron oxide crystals, and colloidal gold, have been employed in targeted therapies for cancer. Both passive and active targeting strategies can be utilized for nanodrug delivery. Passive targeting is based on the enhanced permeability and retention (EPR) effect of the vasculature surrounding tumors. Active targeting relies on ligand-directed binding of nanoparticles to receptors expressed by tumor cells. Release of loaded drugs from nanoparticles may be controlled in response to changes in environmental condition such as temperature and pH. Biodistribution profiles and anticancer efficacy of nano-drugs in vivo would be different depending upon their size, surface charge, PEGylation and other biophysical properties. This review focuses on the recent development of nanoparticles for tumor targeted therapies, including physicochemical properties, tumor targeting, control of drug release, pharmacokinetics, anticancer efficacy and safety. Future perspectives are discussed as well.

Loading

Article metrics loading...

/content/journals/cdm/10.2174/138920010791110827
2010-02-01
2025-06-12
Loading full text...

Full text loading...

/content/journals/cdm/10.2174/138920010791110827
Loading

  • Article Type:
    Research Article
Keyword(s): Nanoparticles; pharmacokinetics; release; safety; tumor targeting
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test